![]() |
|
|
Vol. 57, Issue 6, 1173-1181, June 2000
Department of Pharmacology and Institute of Natural Medicine,
College of Medicine, Hallym University, Chunchon, Kangwon-Do, Republic
of Korea.
The effect of cycloheximide (CHX; 5 mg/kg) on proenkephalin (proENK)
and tyrosine hydroxylase (TH) mRNA expression in rat central and
peripheral nervous systems was studied. CHX increased proENK and TH
mRNA levels in the adrenal gland, but not in hippocampus, striatum,
midbrain, brainstem, pituitary, and hypothalamus. The pretreatment with
actinomycin D (0.5 mg/kg) significantly decreased CHX-induced proENK
and TH mRNA expression, suggesting that the CHX-dependent increase of
these mRNA levels may be caused by the increase of transcriptional
activity rather than RNA stabilization. To investigate the factors
involved in CHX-induced proENK and TH mRNA expression, the effect of
CHX on activator protein-1 (AP-1), cAMP response element (CRE) binding
protein (CREB), and glucocorticoid response element (GRE) was tested.
In AP-1, the basal expression of Fra-2 and c-Jun proteins and AP-1 DNA
binding activity in the adrenal medulla was higher than other tissues
tested, but CHX reduced these protein levels and AP-1 DNA binding
activity. In CREB, CHX time dependently increased the level of
phospho-CREB without altering total CRE level and CRE DNA binding
activity. Furthermore, phospho-CREB actively participated in CRE DNA
binding activity. In GRE, although CHX increased plasma and adrenal
corticosterone level, RU486 (10 mg/kg) reduced CHX-induced proENK, but
not TH, mRNA level in a partial manner. These results suggest that the basal expression of proENK and TH mRNA transcription in the adrenal gland seems to be tonically inhibited by de novo protein synthesis. In
addition, CHX-dependent increase of proENK and TH mRNA expression in
the adrenal medulla is well correlated with phospho-CREB level, but not
AP-1. Finally, glucocorticoid seems to be involved at least partially
in CHX-dependent proENK, but not TH, mRNA expression in the adrenal medulla.
This article has been cited by other articles:
![]() |
J. Ye, L. Gradoville, D. Daigle, and G. Miller De Novo Protein Synthesis Is Required for Lytic Cycle Reactivation of Epstein-Barr Virus, but Not Kaposi's Sarcoma-Associated Herpesvirus, in Response to Histone Deacetylase Inhibitors and Protein Kinase C Agonists J. Virol., September 1, 2007; 81(17): 9279 - 9291. [Abstract] [Full Text] [PDF] |
||||